Major League Baseball has already taken several steps toward modernizing its relationship with cannabis, raising an increasingly common question among fans and marketers: could cannabis branding or sponsorship one day appear in professional baseball? While that possibility remains uncertain, recent policy shifts, cultural trends, and commercial realities suggest the conversation is moving closer to the center of the table than ever before.
MLB’s stance on cannabis has transformed dramatically during the last decade. The league removed marijuana from its drugs of abuse testing list in 2019, a decision widely seen as an acknowledgment of shifting national attitudes. Although players can still face disciplinary action for impairment during games or team activities, the policy signaled MLB’s willingness to rethink outdated approaches. At the same time, front offices have reported fewer off-field issues related to cannabis, further easing old concerns. For advocates, that progress is a meaningful precursor to a wider discussion about commercial partnerships.
Leagues such as the NBA and NHL have already begun exploring relationships with CBD brands, creating a blueprint MLB executives cannot ignore. The BIG3 basketball league, for example, became the first professional sports organization to welcome CBD sponsorship on jerseys and courts. Its success in attracting new revenue and wellness-focused partners sparked interest across the larger sports industry. Pro baseball, known for its conservative sponsorship structure, is evaluating these developments with its usual caution.
The primary obstacle for MLB is the patchwork of cannabis laws across the United States. More than half of the country now permits recreational sales, and nearly every state allows some form of medical use. Even so, federal illegality continues to complicate national campaigns. Most major MLB sponsors—banking, beverage, financial services, telecommunications—operate across all 30 markets, which makes compliance essential. League officials know that any cannabis-related partnership would require airtight legal guidance and strict product-safety standards.
Another barrier is family-friendly branding expectations. MLB prides itself on appealing to all age groups, and league executives have historically avoided categories that could jeopardize that image. However, the growth of regulated cannabis wellness brands—particularly those producing non-intoxicating CBD or cannabinoid-based recovery products—may eventually reshape perceptions. If the category continues trending toward health, science, and athlete recovery, the league’s comfort level could improve.
Players themselves may be the most influential catalyst. As more athletes across pro sports share personal stories about pain management, sleep improvement, and post-career wellness, the stigma around cannabinoids continues to fade. Retired baseball players have quietly entered the industry, and several active athletes have expressed support for expanded research on cannabis-based recovery. Their voices carry weight, especially when tied to evidence-driven conversations about player safety and long-term health.
For now, MLB remains cautious. Still, insiders acknowledge that future sponsorship frameworks could evolve, especially if federal reform accelerates or if CBD partnerships continue proving successful in other leagues. The sport’s marketing ecosystem is always searching for fresh revenue and new audience segments. Should cannabis brands meet the league’s standards for safety, responsibility, and compliance, baseball may eventually determine that the category belongs within its commercial lineup.
In short, pro baseball is not ready to open the door yet—but it has definitely unlocked it.

